It will soon be possible to implement 3D-printing in medicine. Consider what it would be like to be able to print drugs at the point of need and to utilize software apps for drug formulation design and production.
Does this sound too futuristic? Reality is that FDA in 2014 for the first time approved a 3D-printed dosage form, Spritam®. This product is manufactured using the ZipDose® platform technology for an antiepileptic drug. The product was launched on the marked March 2016.
BUT, not only are applications within 3D-printed medicine rapidly developing, also printing of material for medical applications shows huge potential for example in creating bone repair for cancer patients.
These recent developments lead us to question, if we are at the very beginning of a new era for the pharmaceutical industry? We invite you to join us at this seminar, where leading scientists will enlighten us on the use of 3D-printing within the area.
14.00-15.00 3D-printed medicine: a new era for the pharmaceutical industry?
Lee Croning, Professor & Chair of Chemistry, Glasgow University
15.00-15.45 3D-printed medical devices from a clinical perspective
Cody Bünger, Clinical Professor, Aarhus University Hospital
15.45-16.15 Break with refreshments
16.15-16.35 Where are we now with 3D printing in Denmark? Status from Damvig, a Danish 3D printing company
Jesper Damvig, Damvig Develop 3D-printed solutions
16.35-17.05 What to consider before 3D printing can fulfill its real potential in the pharma business
Natalja Genina, Assistant Professor, University of Copenhagen
17.05-17.30 Discussion and wrap up
Registration no later than 20th of January via www.farmaceutisk-selskab.dk.
No entry fee, non-members are also welcome to participate in the meeting.